Published in N Engl J Med on March 28, 2002
A clinical outcome-based prospective study on venous thromboembolism after cancer surgery: the @RISTOS project. Ann Surg (2006) 2.97
Thromboembolic Complications and Prophylaxis Patterns in Colorectal Surgery. JAMA Surg (2015) 2.40
Postoperative enoxaparin prevents symptomatic venous thromboembolism in high-risk plastic surgery patients. Plast Reconstr Surg (2011) 1.65
Validation of the Caprini risk assessment model in plastic and reconstructive surgery patients. J Am Coll Surg (2010) 1.47
Venous thromboembolic disease and cancer. Postgrad Med J (2006) 1.23
Venous thromboembolism prophylaxis and treatment in cancer: a consensus statement of major guidelines panels and call to action. J Clin Oncol (2009) 1.21
New insights into cancer-associated thrombosis. Arterioscler Thromb Vasc Biol (2009) 1.11
Venous thromboembolism in the patient with cancer: focus on burden of disease and benefits of thromboprophylaxis. Cancer (2010) 1.10
Venous thromboembolism and survival in patients with high-grade glioma. Neuro Oncol (2007) 1.07
Venous thromboembolism after surgery for inflammatory bowel disease: are there modifiable risk factors? Data from ACS NSQIP. Dis Colon Rectum (2012) 1.06
Prevention of venous thromboembolism in body contouring surgery: a national survey of 596 ASPS surgeons. Ann Plast Surg (2011) 1.02
Rationale and design of PROSPECT-CONKO 004: a prospective, randomized trial of simultaneous pancreatic cancer treatment with enoxaparin and chemotherapy). BMC Cancer (2008) 1.02
A validated risk model to predict 90-day VTE events in postsurgical patients. Chest (2014) 0.99
Risk of venous thromboembolism outweighs post-hepatectomy bleeding complications: analysis of 5651 National Surgical Quality Improvement Program patients. HPB (Oxford) (2012) 0.96
Cancer-associated thrombosis: prevention and treatment. Curr Oncol (2008) 0.95
Stroke and Cancer- A Complicated Relationship. J Neurol Transl Neurosci (2015) 0.93
Venous thromboembolic disease. J Natl Compr Canc Netw (2011) 0.93
The effect of postoperative enoxaparin on risk for reoperative hematoma. Plast Reconstr Surg (2012) 0.92
Venous thromboembolism risk factor assessment and prophylaxis. Phlebology (2010) 0.92
Thromboprophylaxis with low-molecular-weight heparin in medical patients with cancer. Cancer (2009) 0.90
Randomized controlled trial to investigate the impact of anticoagulation on the incidence of splenic or portal vein thrombosis after laparoscopic splenectomy. Can J Surg (2011) 0.90
The effect of extended post-discharge chemical thromboprophylaxis on venous thromboembolism rates after bariatric surgery: a prospective comparison trial. Surg Endosc (2008) 0.89
Perioperative pharmacologic prophylaxis for venous thromboembolism in colorectal surgery. J Am Coll Surg (2011) 0.89
Cancer and venous thromboembolic disease: from molecular mechanisms to clinical management. Curr Oncol (2014) 0.88
Are There Any Differences in the Clinical and Economic Outcomes Between US Cancer Patients Receiving Appropriate or Inappropriate Venous Thromboembolism Prophylaxis? J Oncol Pract (2009) 0.88
Venous thromboembolism (VTE) rates following the implementation of extended duration prophylaxis for patients undergoing surgery for gynecologic malignancies. Gynecol Oncol (2012) 0.88
Prophylactic and therapeutic anticoagulation for thrombosis: major issues in oncology. Nat Clin Pract Oncol (2008) 0.87
The potential benefits of low-molecular-weight heparins in cancer patients. J Hematol Oncol (2010) 0.87
The effect of increased hip flexion using stirrups on lower-extremity venous flow: a prospective observational study. Am J Surg (2011) 0.87
Primary prevention of venous thromboembolism in medical and surgical oncology patients. Br J Cancer (2010) 0.86
Extended-duration rivaroxaban thromboprophylaxis in acutely ill medical patients: MAGELLAN study protocol. J Thromb Thrombolysis (2011) 0.86
Comparative assessment of low-molecular-weight heparins in cancer from the perspective of patient outcomes and survival. Patient Relat Outcome Meas (2011) 0.85
Thrombotic complications following liver resection for colorectal metastases are preventable. HPB (Oxford) (2008) 0.84
Guidelines for Perioperative Care in Bariatric Surgery: Enhanced Recovery After Surgery (ERAS) Society Recommendations. World J Surg (2016) 0.84
Symptomatic venous thromboembolism in Asian colorectal cancer surgery patients. World J Surg (2011) 0.84
Venous gangrene and cancer: a cool look at a burning issue. Int Semin Surg Oncol (2007) 0.84
Long-term activation of the pro-coagulant response after neoadjuvant chemoradiation and major cancer surgery. Br J Cancer (2009) 0.84
Venous thromboembolic disease in colorectal patients. Clin Colon Rectal Surg (2009) 0.83
Risk of Post-Discharge Venous Thromboembolism and Associated Mortality in General Surgery: A Population-Based Cohort Study Using Linked Hospital and Primary Care Data in England. PLoS One (2015) 0.81
Guidelines for treatment and prevention of venous thromboembolism among patients with cancer. Thromb Res (2014) 0.80
Evaluation of 99mTc-labeled cyclic RGD peptide with a PEG4 linker for thrombosis imaging: comparison with DMP444. Bioconjug Chem (2011) 0.80
Cancer and coagulation. Am J Hematol (2012) 0.80
Differentiation of parenteral anticoagulants in the prevention and treatment of venous thromboembolism. Thromb J (2011) 0.80
Cancer and thrombosis: an increasingly important association. Support Care Cancer (2008) 0.80
Deep vein thrombosis: validation of a patient-reported leg symptom index. Health Qual Life Outcomes (2003) 0.79
Fast-track surgery in gynaecology and gynaecologic oncology: a review of a rolling clinical audit. ISRN Surg (2012) 0.79
Incidence and predictors of venous thromboembolism after debulking surgery for epithelial ovarian cancer. Int J Gynecol Cancer (2013) 0.79
Venous thromboembolism in urologic surgery: prophylaxis, diagnosis, and treatment. Rev Urol (2010) 0.79
Venous thromboembolism in cancer patients: an underestimated major health problem. World J Surg Oncol (2015) 0.79
Primary prevention of venous thromboembolism in elderly medical patients. Clin Interv Aging (2008) 0.78
Effectiveness and safety of expanded perioperative thromboprophylaxis in complex gynecologic surgery. Gynecol Oncol (2015) 0.78
Prolonged use of thromboprophylaxis may not be necessary in laparoscopic colorectal surgery. Int J Colorectal Dis (2011) 0.78
Distinct predictors of pre- versus post-discharge venous thromboembolism after hepatectomy: analysis of 7621 NSQIP patients. HPB (Oxford) (2013) 0.78
Cancer and Venous Thromboembolic Disease: A Review. Oncologist (2017) 0.78
Surgical operative time increases the risk of deep venous thrombosis and pulmonary embolism in robotic prostatectomy. JSLS (2014) 0.78
Predicting the risks of venous thromboembolism versus post-pancreatectomy haemorrhage: analysis of 13,771 NSQIP patients. HPB (Oxford) (2013) 0.77
Primary prevention and treatment of venous thromboembolic events in patients with gastrointestinal cancers - Review. World J Gastrointest Oncol (2016) 0.77
Clinical use of the low-molecular-weight heparins in cancer patients: focus on the improved patient outcomes. Thrombosis (2011) 0.77
Preoperative Chemoprophylaxis Is Safe in Major Oncology Operations and Effective at Preventing Venous Thromboembolism. J Am Coll Surg (2015) 0.77
Highest risk of symptomatic venous thromboembolic events after radical cystectomy occurs in patients with obesity or nonurothelial cancers. Urol Ann (2015) 0.77
Enhanced Recovery after Urological Surgery: A Contemporary Systematic Review of Outcomes, Key Elements, and Research Needs. Eur Urol (2016) 0.76
New anticoagulants for the prevention of venous thromboembolism. Drug Des Devel Ther (2010) 0.76
Patient optimization for surgery relating to Crohn's disease. Nat Rev Gastroenterol Hepatol (2016) 0.75
Diagnosis of VTE postdischarge for major abdominal and pelvic oncologic surgery: implications for a change in practice. Can J Surg (2015) 0.75
Venous thromboembolism prophylaxis in patients undergoing abdominal and pelvic cancer surgery: adherence and compliance to ACCP guidelines in DIONYS registry. Springerplus (2016) 0.75
Prescription of extended-duration thromboprophylaxis after high-risk, abdominopelvic cancer surgery. Gynecol Oncol (2016) 0.75
Prevention of venous thromboembolism with enoxaparin in bariatirc surgery. J Korean Surg Soc (2013) 0.75
Three-year experience of prophylactic placement of inferior vena cava filters in women with gynecological cancer. Int J Gen Med (2013) 0.75
The limited utility of currently available venous thromboembolism risk assessment tools in gynecological oncology patients. Am J Obstet Gynecol (2016) 0.75
Extended venous thromboembolism prophylaxis for high-risk patients undergoing surgery for malignancy. Case Rep Oncol (2011) 0.75
Update in perioperative medicine. J Gen Intern Med (2006) 0.75
Perioperative Considerations in Metastatic Renal Cell Carcinoma. Rev Urol (2016) 0.75
Agreement of four competing guidelines on prevention of venous thromboembolism and comparison with observed physician practices: a cross-sectional study of 1,032 medical inpatients. J Gen Intern Med (2004) 0.75
Supratherapeutic anti-factor Xa levels in patients receiving prophylactic doses of enoxaparin: A case series. Int J Surg Case Rep (2016) 0.75
Management of venous thromboembolism in patients with cancer: role of dalteparin. Vasc Health Risk Manag (2008) 0.75
Venous thromboembolism following colorectal surgery for suspected or confirmed malignancy. Thrombosis (2011) 0.75
Anaesthetic perioperative management of patients with pancreatic cancer. World J Gastroenterol (2014) 0.75
Venous thromboembolism after radical cystectomy: Experience with screening ultrasonography. Arab J Urol (2015) 0.75
Changes in soluble fibrin levels during the perioperative period of gynecologic cancer surgery. Oncol Lett (2012) 0.75
Venous Thromboembolism in Minimally Invasive Compared With Open Hysterectomy for Endometrial Cancer. Obstet Gynecol (2016) 0.75
Improving adherence to guidelines for extended venous thromboembolism prophylaxis in patients with colorectal cancer. BMJ Qual Improv Rep (2013) 0.75
Venous thromboembolic events in minimally invasive gynecologic surgery. J Minim Invasive Gynecol (2013) 0.75
The Hemostasis Apparatus in Pancreatic Cancer and Its Importance beyond Thrombosis. Cancers (Basel) (2011) 0.75
Venous Thromboembolism in Cancer: An Update of Treatment and Prevention in the Era of Newer Anticoagulants. Front Cardiovasc Med (2016) 0.75
Safety of fondaparinux to prevent venous thromboembolism in Japanese patients undergoing colorectal cancer surgery: a multicenter study. Surg Today (2014) 0.75
Management of cancer-associated venous thrombosis. Vasc Health Risk Manag (2006) 0.75
Prophylaxis against venous thromboembolism after surgery for cancer. N Engl J Med (2002) 0.75
Practice patterns in venous thromboembolism (VTE) prophylaxis in thoracic surgery: a comprehensive Canadian Delphi survey. J Thorac Dis (2017) 0.75
Defining high risk: cost-effectiveness of extended-duration thromboprophylaxis following major oncologic abdominal surgery. J Gastrointest Surg (2013) 0.75
Visualization of in vivo thromboprophylactic and thrombolytic efficacy of enoxaparin in laser-induced vascular endothelial injury model using multiphoton microscopy. Am J Transl Res (2015) 0.75
Antithrombotic therapy for prophylaxis and treatment of venous thromboembolism in patients with cancer: review of the literature on current practice and emerging options. ESMO Open (2017) 0.75
Incidence of pulmonary thromboembolism in gastric cancer surgery using routine thromboprophylaxis. Gastric Cancer (2010) 0.75
[Perioperative thromboprophylaxis in adults]. Wien Med Wochenschr (2009) 0.75
Guidelines on the diagnosis and management of acute pulmonary embolism: the Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC). Eur Heart J (2008) 12.31
Oral rivaroxaban for the treatment of symptomatic pulmonary embolism. N Engl J Med (2012) 11.86
Aspirin for preventing the recurrence of venous thromboembolism. N Engl J Med (2012) 10.64
Oral rivaroxaban for symptomatic venous thromboembolism. N Engl J Med (2010) 9.92
Fibrinolysis for patients with intermediate-risk pulmonary embolism. N Engl J Med (2014) 9.33
Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest (2008) 7.12
2014 ESC guidelines on the diagnosis and management of acute pulmonary embolism. Eur Heart J (2014) 6.32
Antithrombotic therapy for venous thromboembolic disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest (2004) 5.96
Critical issues in peripheral arterial disease detection and management: a call to action. Arch Intern Med (2003) 4.72
Residual thrombosis on ultrasonography to guide the duration of anticoagulation in patients with deep venous thrombosis: a randomized trial. Ann Intern Med (2009) 4.27
Randomized, placebo-controlled trial of dalteparin for the prevention of venous thromboembolism in acutely ill medical patients. Circulation (2004) 3.83
Venous thromboembolism (VTE) in Europe. The number of VTE events and associated morbidity and mortality. Thromb Haemost (2007) 3.67
A randomized study on 1-week versus 4-week prophylaxis for venous thromboembolism after laparoscopic surgery for colorectal cancer. Ann Surg (2014) 3.43
Thrombolysis compared with heparin for the initial treatment of pulmonary embolism: a meta-analysis of the randomized controlled trials. Circulation (2004) 2.69
Efficacy and safety of anticoagulant treatment in acute cardioembolic stroke: a meta-analysis of randomized controlled trials. Stroke (2007) 2.60
Prognostic value of troponins in acute pulmonary embolism: a meta-analysis. Circulation (2007) 2.54
Factors related to heart rupture in acute coronary syndromes in the Global Registry of Acute Coronary Events. Eur Heart J (2010) 2.52
Risk factors for venous thromboembolism in hospitalized patients with acute medical illness: analysis of the MEDENOX Study. Arch Intern Med (2004) 2.34
Oral rivaroxaban versus standard therapy for the treatment of symptomatic venous thromboembolism: a pooled analysis of the EINSTEIN-DVT and PE randomized studies. Thromb J (2013) 2.21
Preoperative or postoperative start of prophylaxis for venous thromboembolism with low-molecular-weight heparin in elective hip surgery? Arch Intern Med (2002) 2.16
Enoxaparin for the prevention of venous thromboembolism associated with central vein catheter: a double-blind, placebo-controlled, randomized study in cancer patients. J Clin Oncol (2005) 2.14
Venous thromboembolism associated with long-term use of central venous catheters in cancer patients. J Clin Oncol (2003) 2.13
Rivaroxaban: population pharmacokinetic analyses in patients treated for acute deep-vein thrombosis and exposure simulations in patients with atrial fibrillation treated for stroke prevention. Clin Pharmacokinet (2011) 2.09
Estimated annual numbers of US acute-care hospital patients at risk for venous thromboembolism. Am J Hematol (2007) 2.06
Incidence of chronic thromboembolic pulmonary hypertension after a first episode of pulmonary embolism. Chest (2006) 1.85
A prospective study on cardiovascular events after acute pulmonary embolism. Eur Heart J (2004) 1.80
Anticoagulants in heart disease: current status and perspectives. Eur Heart J (2007) 1.73
Bolus tenecteplase for right ventricle dysfunction in hemodynamically stable patients with pulmonary embolism. Thromb Res (2009) 1.72
Long term follow-up after splenectomy performed for immune thrombocytopenic purpura (ITP). Am J Hematol (2003) 1.70
Long-haul flights and deep vein thrombosis: a significant risk only when additional factors are also present. Br J Haematol (2002) 1.67
A modified Khorana risk assessment score for venous thromboembolism in cancer patients receiving chemotherapy: the Protecht score. Intern Emerg Med (2012) 1.67
Efficacy and safety of fixed low-dose dalteparin in preventing venous thromboembolism among obese or elderly hospitalized patients: a subgroup analysis of the PREVENT trial. Arch Intern Med (2005) 1.64
Early hemorrhagic transformation of brain infarction: rate, predictive factors, and influence on clinical outcome: results of a prospective multicenter study. Stroke (2008) 1.63
Association of persistent right ventricular dysfunction at hospital discharge after acute pulmonary embolism with recurrent thromboembolic events. Arch Intern Med (2006) 1.56
Risk factors for upper limb deep vein thrombosis associated with the use of central vein catheter in cancer patients. Intern Emerg Med (2008) 1.54
Combined oral anticoagulants and antiplatelets: benefits and risks. Intern Emerg Med (2010) 1.39
Impact of combined pharmacologic treatment with clopidogrel and a statin on outcomes of patients with non-ST-segment elevation acute coronary syndromes: perspectives from a large multinational registry. Eur Heart J (2005) 1.39
Complications and functional outcomes after total hip arthroplasty and total knee arthroplasty: results from the Global Orthopaedic Registry (GLORY). Am J Orthop (Belle Mead NJ) (2010) 1.25
Venous thromboembolism risk and prophylaxis in hospitalised medically ill patients. The ENDORSE Global Survey. Thromb Haemost (2010) 1.21
Mortality rates and risk factors for asymptomatic deep vein thrombosis in medical patients. Thromb Haemost (2005) 1.19
Oral direct factor Xa inhibition with edoxaban for thromboprophylaxis after elective total hip replacement. A randomised double-blind dose-response study. Thromb Haemost (2010) 1.14
Incidence of thrombotic complications in patients with haematological malignancies with central venous catheters: a prospective multicentre study. Br J Haematol (2005) 1.14
Intravenous thrombolysis with rt-PA in acute ischemic stroke patients aged older than 80 years in Italy. Cerebrovasc Dis (2007) 1.12
Outcome in patients with stroke associated with internal carotid artery occlusion. Cerebrovasc Dis (2005) 1.12
Activation, processing and trafficking of extracellular heparanase by primary human fibroblasts. J Cell Sci (2002) 1.12
Randomised, double blind, multicentre, placebo controlled study of sulodexide in the treatment of venous leg ulcers. Thromb Haemost (2002) 1.09
Prevention of venous thromboembolism in medical patients with enoxaparin: a subgroup analysis of the MEDENOX study. Blood Coagul Fibrinolysis (2003) 1.08
What is the optimal pharmacological prophylaxis for the prevention of deep-vein thrombosis and pulmonary embolism in patients with acute ischemic stroke? Thromb Res (2006) 1.08
Aspirin versus low-molecular-weight heparin after total hip arthroplasty. Ann Intern Med (2013) 1.06
Efficacy and safety of a prothrombin complex concentrate (Octaplex) for rapid reversal of oral anticoagulation. Thromb Res (2004) 1.05
The concept of ischemic penumbra in acute stroke and therapeutic opportunities. Eur Neurol (2009) 1.05
Heparin for the prevention of venous thromboembolism in general medical patients (excluding stroke and myocardial infarction). Cochrane Database Syst Rev (2009) 1.04
Venous thromboembolism risk and prophylaxis in the acute care hospital setting (ENDORSE survey): findings in surgical patients. Ann Surg (2010) 1.02
Third-trimester unexplained intrauterine fetal death is associated with inherited thrombophilia. Obstet Gynecol (2002) 1.02
Clinical characteristics and management of cancer-associated acute venous thromboembolism: findings from the MASTER Registry. Haematologica (2008) 1.00
Long-term outcomes of patients with cerebral vein thrombosis: a multicenter study. J Thromb Haemost (2012) 0.99
IGIV-C, a novel intravenous immunoglobulin: evaluation of safety, efficacy, mechanisms of action, and impact on quality of life. Thromb Haemost (2004) 0.99
Hormone replacement therapy and stroke. Curr Vasc Pharmacol (2008) 0.99
Old and new oral anticoagulants for venous thromboembolism and atrial fibrillation: a review of the literature. Thromb Res (2012) 0.99
Risk of recurrent cerebrovascular events in patients with cryptogenic stroke or transient ischemic attack and patent foramen ovale: the FORI (Foramen Ovale Registro Italiano) study. Cerebrovasc Dis (2010) 0.99
Prophylaxis against venous thromboembolism in patients with cancer. N Engl J Med (2014) 0.98
Effect of on-admission antiplatelet treatment on patients with cerebral hemorrhage. Cerebrovasc Dis (2007) 0.97
Anti-platelet factor 4/heparin antibodies from patients with heparin-induced thrombocytopenia provoke direct activation of microvascular endothelial cells. Int Immunol (2002) 0.96
Systemic thrombolysis in patients with acute ischemic stroke and Internal Carotid ARtery Occlusion: the ICARO study. Stroke (2011) 0.96
Economic burden of long-term complications of deep vein thrombosis after total hip replacement surgery in the United States. Value Health (2003) 0.95
Gender differences in patients with acute ischemic stroke. Womens Health (Lond Engl) (2010) 0.95
Interpretation of normative thyroid volumes in children and adolescents: is there a need for a multivariate model? Thyroid (2004) 0.94
96 hours ECG monitoring for patients with ischemic cryptogenic stroke or transient ischaemic attack. Intern Emerg Med (2012) 0.93
Impact of prior peripheral arterial disease and stroke on outcomes of acute coronary syndromes and effect of evidence-based therapies (from the Global Registry of Acute Coronary Events). Am J Cardiol (2007) 0.93
Endothelial dysfunction in patients with spontaneous venous thromboembolism. Haematologica (2007) 0.93
Combining warfarin and antiplatelet therapy after coronary stenting in the Global Registry of Acute Coronary Events: is it safe and effective to use just one antiplatelet agent? Eur Heart J (2007) 0.92
Direct oral anticoagulants in patients with VTE and cancer: a systematic review and meta-analysis. Chest (2015) 0.92
Multidetector CT scan for acute pulmonary embolism: embolic burden and clinical outcome. Chest (2012) 0.91
The stress-associated acetylcholinesterase variant AChE-R is expressed in human CD34(+) hematopoietic progenitors and its C-terminal peptide ARP promotes their proliferation. Exp Hematol (2002) 0.91
Statins and stroke prevention. Cerebrovasc Dis (2007) 0.91
Clinically overt venous thromboembolism after urologic cancer surgery: results from the @RISTOS Study. Eur Urol (2006) 0.90
Clinical features and short term outcomes of patients with acute pulmonary embolism. The Italian Pulmonary Embolism Registry (IPER). Thromb Res (2012) 0.90
Acute hyperglycemia and early hemorrhagic transformation in ischemic stroke. Cerebrovasc Dis (2009) 0.90
Admission leukocytosis in acute cerebral ischemia: influence on early outcome. J Stroke Cerebrovasc Dis (2011) 0.90
Appendiceal abscesses: primary percutaneous drainage and selective interval appendicectomy. Eur J Surg (2002) 0.90
Heparin for the prevention of venous thromboembolism in acutely ill medical patients (excluding stroke and myocardial infarction). Cochrane Database Syst Rev (2014) 0.90
Multidetector computed tomography for acute pulmonary embolism: diagnosis and risk stratification in a single test. Eur Heart J (2011) 0.89
Obesity and the risk of intracerebral hemorrhage: the multicenter study on cerebral hemorrhage in Italy. Stroke (2013) 0.89
Factors associated with the timing of diagnosis of venous thromboembolism: results from the MASTER registry. Thromb Res (2007) 0.89
Chemotherapy-associated thromboembolic risk in cancer outpatients and effect of nadroparin thromboprophylaxis: results of a retrospective analysis of the PROTECHT study. J Transl Med (2011) 0.89
Early seizures in patients with acute stroke: frequency, predictive factors, and effect on clinical outcome. Vasc Health Risk Manag (2008) 0.88
Complex regulation of acetylcholinesterase gene expression in human brain tumors. Oncogene (2002) 0.88
Seasonal variation in the occurrence of venous thromboembolism: data from the MASTER Registry. Clin Appl Thromb Hemost (2008) 0.88
Heparanase expression in human leukemias is restricted to acute myeloid leukemias. Exp Hematol (2002) 0.88
Runx1/AML1 in leukemia: disrupted association with diverse protein partners. Leuk Res (2002) 0.87
Improving Practices in US Hospitals to Prevent Venous Thromboembolism: lessons from ENDORSE. Am J Med (2010) 0.87
D-dimer for risk stratification in patients with acute pulmonary embolism. J Thromb Thrombolysis (2012) 0.87
Determinants of outcome in patients eligible for thrombolysis for ischemic stroke. Vasc Health Risk Manag (2007) 0.86
Novel approaches to the treatment of thrombosis. Trends Pharmacol Sci (2002) 0.86